Hemozoin as a Diagnostic Biomarker: A Scoping Review of Next-Generation Malaria Detection Technologies
Biosensors · 2026
DOI: 10.3390/bios16010048 ↗At a glance
Scoping Review in Biosensors, 2026. Written by Afiat Berbudi and 3 co-authors. Institution: Department of Biomedical Sciences, Parasitology Division, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, Indonesia. Major MEDLINE topics: Hemeproteins, Malaria, Biosensing Techniques. Cited 3 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: Indonesian Endowment Fund for Education (LPDP) of the Ministry of Higher Education, Science, and Technology.
Abstract (original language)
Accurate malaria diagnosis is essential for effective case management and transmission control; however, the sensitivity, operational requirements, and field applicability of current conventional methods are limited. Hemozoin, an optically and magnetically active crystalline biomarker produced by Plasmodium species, offers a reagent-free target for next-generation diagnostics. This scoping review, following PRISMA-ScR and Joanna Briggs Institute guidance, synthesizes recent advances in hemozoin-based detection technologies and maps the current landscape. Twenty-four studies were reviewed, spanning eight major technology classes: magneto-optical platforms, magnetophoretic microdevices, photoacoustic detection, Raman/SERS spectroscopy, optical and hyperspectral imaging, NMR relaxometry, smartphone-based microscopy, and flow cytometry. Magneto-optical systems—including Hz-MOD, Gazelle™, and RMOD—demonstrated the highest operational readiness, with robust specificity but reduced sensitivity at low parasitemia. Photoacoustic Cytophone studies demonstrated promising sensitivity and noninvasive in vivo detection. Raman/SERS platforms achieved sub-100 infected cell/mL analytical sensitivity but remain laboratory-bound. Microfluidic and smartphone-based tools offer emerging, potentially low-cost alternatives. Across modalities, performance varied by parasite stage, with reduced detection of early ring forms. In conclusion, hemozoin-targeted diagnostics represent a rapidly evolving field with multiple viable translational pathways. While magneto-optical devices are closest to field deployment, further clinical validation, improved low-density detection, and standardized comparison across platforms are needed to support future adoption in malaria-endemic settings.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biomedical Sciences, Parasitology Division, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, Indonesia.
- Research Center for Care and Control of Infectious Diseases (RC3ID), Universitas Padjadjaran, Bandung 40161, Indonesia.
- Department of Biomedical Sciences, Cell Biology Division, Faculty of Medicine, Universitas Padjadjaran, Bandung 40161, Indonesia.
- Veterinary Medicine Program, Faculty of Medicine, Universitas Padjadjaran, Sumedang 45363, Indonesia.
- Department of Biochemistry and Biotechnology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
- Central Research Laboratory, Nigerian Institute of Medical Research, Yaba, Lagos P.O. Box P.M.B. 2013, Nigeria.
ORCID profiles: Afiat Berbudi, Shafia Khairani, Alexander Kwarteng, Ngozi Mirabel Otuonye
Funding
- Indonesian Endowment Fund for Education (LPDP) of the Ministry of Higher Education, Science, and Technology
Cite
APA
Berbudi, A., Khairani, S., Kwarteng, A., & Otuonye, N. M. (2026). Hemozoin as a Diagnostic Biomarker: A Scoping Review of Next-Generation Malaria Detection Technologies. Biosensors. https://doi.org/10.3390/bios16010048
Vancouver
Berbudi A, Khairani S, Kwarteng A, Otuonye NM. Hemozoin as a Diagnostic Biomarker: A Scoping Review of Next-Generation Malaria Detection Technologies. Biosensors. 2026. doi:10.3390/bios16010048
BibTeX
@article{Berbudi2026,
author = {Berbudi, Afiat and Khairani, Shafia and Kwarteng, Alexander and Otuonye, Ngozi Mirabel},
title = {Hemozoin as a Diagnostic Biomarker: A Scoping Review of Next-Generation Malaria Detection Technologies},
journal = {Biosensors},
year = {2026},
doi = {10.3390/bios16010048}
}
EUVIMED